Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-06-005263
Filing Date
2006-03-01
Accepted
2006-03-01 18:12:37
Documents
1
Period of Report
2006-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 20658
  Complete submission text file 0001179110-06-005263.txt   22585
Mailing Address
Business Address 10165 MCKELLAR CT SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Issuer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 767 FIFTH AVENUE NEW YORK NY 10153
Business Address 25 WEST 43RD STREET SUITE 1014 NEW YORK NY 10036 212 391 7718
WATTLETON FAYE (Reporting) CIK: 0001014156 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 000-10961 | Film No.: 06657258